Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsSNIP is a drug-regulated CAR platform that utilizes an FDA-approved small molecule to enable remote control and a generalizable molecular architecture that does not perturb CAR function.SNIP is a drug-regulated CAR platform that utilizes an FDA-approved small molecule to enable remote control and a generalizable molecular architecture that does not perturb CAR function.Louai Labanieh, Robbie G. Majzner, Dorota Klysz, Elena Sotillo, Chris J. Fisher, José G. Vilches-Moure, Kaithlen Zen B. Pacheco, Meena Malipatlolla, Peng Xu, Jessica H. Hui, Tara Murty, Johanna Theruvath, Nishant Mehta, Sean A. Yamada-Hunter, Evan W. Weber, Sabine Heitzeneder, Kevin R. Parker, Ansuman T. Satpathy, Howard Y. Chang, Michael Z. Lin, Jennifer R. Cochran, Crystal L. Mackallhttps://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900391-9%3Frss%3Dyes&rc=0http://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignApril 28, 2022

Powered by WPeMatico